-
Share
2,795 Posts.
1723
29/08/19
08:32
Share
the key point is that GDC- 0084 is being positioned for a fast path to market.
Kazia has always been clear that it envisages partnering with a larger company to bring GDC-0084 to market,
that partnering transaction could happen at any time during the development of the drug.
We are already actively sharing progress with big pharma companies, and making sure that the emerging data from GDC-0084 is well-understood
-
